PERINATOLOGIYA AND PEDIATRIYA.2019.2(78):58-66; doi 10.15574/PP.2019.78.58

Antipkin Y. G., Kirilova L. G., Miroshnikov A. A., Yuzva A. A.
SI Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine, Kyiv

The article presents a review of current literature data relating to mitochondrial diseases associated with POLG-gene mutations. Diseases of this group have diverse and non-specific clinical manifestations, which makes their diagnosis a difficult task. Such diseases can develop as a result of mutations in their own mitochondrial DNA or nuclear cell genes, similar clinical manifestations, however, may differ in severity of flow and prognosis. The onset of these diseases can occur in the age range from early childhood to adulthood. Based on analysis of various literature sources, modern views on etiology, pathogenesis, clinical and diagnostical characteristics and therapeutic approaches to POLF-related mitochondrial diseases were generalized and systematically examined. Clinical case of a child with mitochondrial neurogastrointestinal encephalopathy, which is an atypical manifestation of POLG-gene mutations was also presented. In the clinical case presented, despite an increase in transaminases in the patient in history, no further liver damage characteristic of Alpers syndrome was observed. Also, the child did not develop catastrophic epileptic seizures resistant to therapy, however, a relatively mild course of epileptic encephalopathy was registered. However, the clinic was dominated by recurrent vomiting, weight loss, refusal to eat and signs of gastrointestinal dysfunction according to instrumental examinations. In this case, molecular genetic research was crucial for the diagnosis. In our opinion, pediatric physicians should have a certain level of alertness and promptly refer children with suspected mitochondrial disease to children's neurologists. Despite the tragic prognosis of certain diseases of this group, errors in their diagnosis are unacceptable. Accurate diagnosis should be made as early as possible. Today, this is possible only with the help of neuroradiological and molecular genetic methods.

Key words: mitochondrial diseases, mitochondrial neurogastrointestinal encephalopathy, molecular genetic diagnosis, POLG gene mutation.

REFERENCES

1. Batisheva et al. (2015). Alopers syndrome. Epilepsy and paroxysmal disorders. 7 (1): 46—55.

2. Alpers BJ. (1931). 7 Diffuse progressive degeneration of the gray matter of the cerebrum. Arch. Neurol. Psychiatry. 25: 469—505. https://doi.org/10.1001/archneurpsyc.1931.02230030027002

3. Anagnostou M, Ng Y, Taylor R and McFarland R. (2016). Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic review. Epilepsia. 57 (10): 1531—1545. https://doi.org/10.1111/epi.13508

4. Bai HX, MA MH et al. (2011). 17 Novel characterization of drag-associated pancreatitis in children. J. Pediatr. Gastroenterol. Nutr. 53: 423—428.

5. Bohan TP, Helton E et al. (2001). 15 Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology. 56: 1405—1409. https://doi.org/10.1212/WNL.56.10.1405

6. Cohen B et al. (2005). POLG-Related Disorders in GeneReviews. Seattle, WA: University of Washington.

7. Eggar J, Harding BN, Boyd SG, Wilson J, Erdohazi M. (1987). Progressive neuronal degeneration of childhood (PNDC) with liver disease. Clin Pediatr. 26: 167—173. https://doi.org/10.1177/000992288702600401

8. Fadic R, Russell JA, Vedanarayanan VV, Lehar M, Kuncl RW, Johns DR. (1997). Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology. 49: 239—245. https://doi.org/10.1212/WNL.49.1.239

9. Ferrari G, Futterer N, Ahola S, Lamantea E, Prokisch H, Lochmuller H, McFarland R, Ramesh V, Klopstock T, Freisinger P, Salvi F, Mayr JA, Santer R, Tesarova M, Zeman J, Udd B, Taylor RW, Turnbull D, Hanna M, Fialho D, Suomalainen A, Zeviani M, Chinnery PF. (2006). Phenotypic spectrum аassociated with mutations of the mitochondrial polymerase gamma gene. Brain. 129: 1674—1684. https://doi.org/10.1093/brain/awl088

10. Filosto M, Mancuso M, Nishigaki Y, Pancrudo J, Harati Y, Gooch C, Mankodi A, Bayne L, Bonilla E, Shanske S, Hirano M and DiMauro S. (2003). Clinical and Genetic Heterogeneity in Progressive External Ophthalmoplegia Due to Mutations in Polymerase γ. Archives of Neurology. 60 (9): 5534. https://doi.org/10.1001/archneur.60.9.1279

11. Genome. JP. (2018). KEGG DISEASE: Mitochondrial neurogastrointestinal encephalomyopathy. [online]. https://www.genome.jp/dbget-bin/www_bget?ds:H01390. Accessed 23 Jul. 2018.

12. Giordano C, Powell H. (2009). Fatal congenital myopathy and gastrointestinal pseudoobstruction due to POLG1 mutations. Neurology. 72: 1103—1105. https://doi.org/10.1212/01.wnl.0000345002.47396.e1

13. Harding BN, Egger J, Portmann B et al. (1986). Progressive neuronal degeneration of childhood with liver disease. A pathological study. Brain. 109: 181—206. https://doi.org/10.1093/brain/109.1.181

14. Harris MO, Walsh LE, Hattab EM, Golomb MR. (2010). Is it ADEM, POLG, or both? Archives of Neurology. 67 (4): 493—496. https://doi.org/10.1001/archneurol.2010.36.

15. Horvath R, HudsAvula, Parikh S, Demarest S, Kurz J and Gropman A. (2014). Treatment of Mitochondrial Disorders. Current Treatment Options in Neurology, 16 (6): 3452. https://doi.org/10.1007/s11940-014-0292-7

16. Huttenlocher PR, Solitare GB, Adams G. (1976). Infantile diffuse cerebral degeneration with hepatic cirrhosis. Arch. Neurol. 33: 186—192. https://doi.org/10.1001/archneur.1976.00500030042009

17. Kurt B, Naini A, Copeland W, Lu J, DiMauro S and Hirano M. (2012). A novel POLG gene mutation in a patient with SANDO. Journal of Experimental and Integrative Medicine. 2 (2): 181. https://doi.org/10.5455/jeim.200312.cr.001

18. Lamantea E, Tiranti V, Bordoni A, Toscano A, Bono F, Servidei S, Papadimitriou A, Spelbrink H, Silvestri L, Casari G, Comi GP, Zeviani M. (2002). Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann. Neurol. 52: 211—219. https://doi.org/10.1002/ana.10278

19. Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, Oldfors A, Rautakorpi I, Peltonen L, Majamaa K, Somer H, Suomalainen A. (2004). Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet. 364: 875—882. https://doi.org/10.1016/S0140-6736(04)16983-3

20. Naviaux RK, Nguyen KV. (2004). POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. Ann. Neurol. 55: 706—712. https://doi.org/10.1002/ana.20079

21. Naviaux RK, Nyhan WL, Barshop BA et al. (1999). Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome. Ann. Neurol. 45: 54—58. https://doi.org/10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B

22. Pereira L, Soares P, Triska P, Rito T, van der Waerden A, Li B, Radivojac P, Samuels D. (2014). Global human frequencies of predicted nuclear pathogenic variants and the role played by protein hydrophobicity in pathogenicity potential. Scientific Reports. 4 (1): 352. https://doi.org/10.1038/srep07155

23. Ropp P and Copeland W. (1996). Cloning and Characterization of the Human Mitochondrial DNA Polymerase, DNA Polymerase γ. Genomics. 36 (3): 449—458. https://doi.org/10.1006/geno.1996.0490

24. Saneto R, Cohen B, Copeland W and Naviaux R. (2013). Alpers-Huttenlocher Syndrome. Pediatric Neurology. 48 (3): 167—178. https://doi.org/10.1016/j.pediatrneurol.2012.09.014

25. Saneto RP, Naviaux RK. (2010). Polymerase gamma disease through the ages. Dev. Disabil. Res. Rev. 16: 163—174. https://doi.org/10.1002/ddrr.105

26. Tang S, Dimberg EL, Milone M, Wong LJ (2012). Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-likephenotype: anexpanded clinical spectrum of POLG1 mutations. J. Neurol. 259: 862—868. https://doi.org/10.1007/s00415-011-6268-6

27. Van Goethem G, Dermaut B, Lofgren A et al. (2001). Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat. Genet. 28: 211—212. https://doi.org/10.1038/90034

28. Wong L-JC, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C, Milone M, Cohen BH, Wical B, Ganesh J, Basinger AA, Burton BK, Swoboda K, Gilbert DL, Vanderver A, Saneto RP, Maranda B, Arnold G, Abdenur JE, Waters PJ, Copeland WC. (2008). Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mut. 29: E150-E172. https://doi.org/10.1002/humu.20824

29. Yakubovskaya E, Chen Z, Carrodeguas JA et al. (2006). Functional humanmitochondrial DNA polymerase γ forms a heterotrimer. J. Biol. Chem. 281: 374—382. https://doi.org/10.1074/jbc.M509730200

Article received: Feb 12, 2019. Accepted for publication: Jun 01, 2019.